Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
Issa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Transplantation and Cellular Therapy
|
June 13, 2025
Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experience
Jitesh D Kawedia, Victoria W Handy, Alan L Myers, et al.
Leukemia & Lymphoma
|
February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors
Akash Mukherjee, Denái R Milton, Elias J Jabbour, et al.
Bone Marrow Transplantation
|
October 17, 2024
Incidence of bacterial blood stream infections in patients with acute GVHD
Whitney Wallis, Alison M Gulbis, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2017
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation
Maria R Khouri, Elias J Jabbour, Alison M Gulbis, et al.
Bone Marrow Transplantation
|
December 23, 2017
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
Brittany Knick Ragon, Rohtesh S Mehta, Alison M Gulbis, et al.
Nature Reviews. Clinical Oncology
|
September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 4, 2019
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
Kamal Chamoun, Denái R Milton, Celina Ledesma, et al.
Leukemia
|
July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cells
Stefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma
Jad Chahoud, Dawen Sui, William D Erwin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
Issa F Khouri, Irina Fernandez Curbelo, Francesco Turturro, et al.
Transplantation and Cellular Therapy
|
June 13, 2025
Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experience
Jitesh D Kawedia, Victoria W Handy, Alan L Myers, et al.
Leukemia & Lymphoma
|
February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors
Akash Mukherjee, Denái R Milton, Elias J Jabbour, et al.
Bone Marrow Transplantation
|
October 17, 2024
Incidence of bacterial blood stream infections in patients with acute GVHD
Whitney Wallis, Alison M Gulbis, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 13, 2017
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation
Maria R Khouri, Elias J Jabbour, Alison M Gulbis, et al.
Bone Marrow Transplantation
|
December 23, 2017
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
Brittany Knick Ragon, Rohtesh S Mehta, Alison M Gulbis, et al.
Nature Reviews. Clinical Oncology
|
September 20, 2017
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 4, 2019
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
Kamal Chamoun, Denái R Milton, Celina Ledesma, et al.
Leukemia
|
July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cells
Stefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2018
Updated Results of Rituximab Pre- and Post-BEAM with or without <sup>90</sup>Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma
Jad Chahoud, Dawen Sui, William D Erwin, et al.
Page
of 3